Skip to content

Author

R. McClenahan

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Cardiovascular and mortality outcomes with JAK versus TNF inhibitors in rheumatoid arthritis: a target trial emulation (CARDINAL-RA)

Objectives This study aims to compare cardiovascular and mortality outcomes of Janus kinase inhibitors (JAKi) versus tumor necrosis factor inhibitors (TNFi) in rheumatoid arthritis (RA) at elevated cardiovascular risk using target trial emulation. Methods Within TriNetX, adults with RA aged ≥50 years and ≥1 cardiovascu...

R. McClenahan, L. Alamlih · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.